Company news

Bio-Techne Corp news in 2024

Bio-Techne Corp's news releases, calls and decks from 2024, newest first.

View company

Bio-Techne to present at the 43rd annual j.p. morgan healthcare conference

December 19, 2024

Bio-Techne announces biotherapeutic characterization strategic co-marketing and co-promotion agreement

December 18, 2024

Bio-Techne announces new distribution agreement with MedSanTek to expand access to portfolio across Turkey

December 11, 2024

Bio-Techne launches ESR1 mutation monitoring assay

December 9, 2024

Bio-Techne to present at the citi 2024 global healthcare conference

November 26, 2024

Bio-Techne announces new distribution agreement with Leader Life Sciences

November 19, 2024

BIO-TECHNE AND ALZpath ANNOUNCE STRATEGIC PARTNERSHIP TO ADVANCE NEURODEGENERATIVE DISEASE RESEARCH

November 17, 2024

Bio-Techne to highlight novel solutions for cancer and carrier screening at AMP 2024 annual meeting & expo

November 13, 2024

Bio-Techne announces IVDR certified hematology controls and Calibrators

November 10, 2024

Bio-Techne to present at investor conferences

November 7, 2024

Bio-Techne to present at the society for immunotherapy of cancer (sitc) 39th annual meeting

November 5, 2024

Lunaphore COMET™ platform paves the way for spatial biology adoption in clinical research

November 4, 2024

Bio-Techne releases first quarter fiscal 2025 results

October 29, 2024

Bio-Techne to host conference call on October 30, 2024, to announce first quarter fiscal 2025 financial results

October 9, 2024

Bio-Techne to present at Neuroscience 2024-the society for Neuroscience (SfN) annual meeting

September 23, 2024

Bio-Techne issues 2024 corporate sustainability report

September 17, 2024

ScaleReady announces a G-Rex® Grant has been awarded to Verismo Therapeutics

September 16, 2024

ScaleReady and Bio-Techne Announce Optimal Closed System Cytokine Packaged for Single Step Use in Closed System G-Rex® Manufacture of CAR-T and TCR Therapies

September 15, 2024

Bio-Techne to present at investor healthcare conferences

August 25, 2024

Bio-Techne releases fourth quarter fiscal 2024 results

August 6, 2024

Bio-Techne announces next-generation high throughput Simple Western System

July 30, 2024

Bio-Techne announces strategic investment in Spear Bio

July 28, 2024

Bio-Techne to host conference call on August 7, 2024, to announce fourth quarter and fiscal 2024 financial results

July 14, 2024

Bio-Techne to present at upcoming investor conferences

May 30, 2024

BIO-TECHNE TO HIGHLIGHT MULTIPLE APPLICATIONS OF THE MauriceFlex™ SYSTEM AT THE ANNUAL ASMS CONFERENCE

May 29, 2024

Bio-Techne to present at the 2024 leerink partners healthcare crossroads conference

May 22, 2024

Bio-Techne highlights recently announced top-line biomarker data from partner, Regulus Therapeutics, using the company's proprietary technology

May 21, 2024

Bio-Techne to present at the bofa securities health care conference 2024

May 7, 2024

Bio-Techne to present at the 27th annual meeting of the american society of gene & cell therapy (ASGCT)

May 6, 2024

Bio-Techne releases third quarter fiscal 2024 results

April 30, 2024

Bio-Techne appoints Dr. Judith Klimovsky to board of directors

April 29, 2024

Bio-Techne announces new distribution agreement with Thermo Fisher Scientific

April 28, 2024

Bio-Techne and Novomol-Dx announce point-of-care ocular biomarker assay

April 25, 2024

Bio-Techne files Patent infringement lawsuit against Molecular Instruments

April 22, 2024

Bio-Techne to host conference call on May 1, 2024, to announce third quarter fiscal 2024 financial results

April 9, 2024

BIO-TECHNE SURPASSES 10,000 PEER-REVIEWED PUBLICATIONS CITING RNAscope TECHNOLOGY

April 7, 2024

Bio-Techne to present at the 2024 american association for cancer research (AACR) conference

April 2, 2024

BIO-TECHNE RECEIVES CiteAb'S ELISA KIT SUPPLIER OF THE YEAR AND SPATIAL BIOLOGY INNOVATION AWARDS

March 31, 2024

Bio-Techne and Nikon Instruments Inc. announce partnership to expand access to innovative spatial biology services

March 27, 2024

Bio-Techne receives european IVDR certification for diagnostic test to monitor chronic myeloid leukemia

March 21, 2024

Bio-Techne to present at the keybanc life sciences & medtech investor forum

March 11, 2024

Bio-Techne to present at the barclays 26th annual global healthcare conference

March 5, 2024

Bio-Techne releases second quarter fiscal 2024 results

January 31, 2024

Bio-Techne's advanced cell diagnostics (ACD) sets new standard in spatial biology with protease-free RNAscope multiomics

January 28, 2024

Lunaphore and ACD revolutionize spatial biology research with the launch of the first fully automated, same-section, hyperplex multiomics application

January 24, 2024

SCIENTISTS AT THE WCBP CONFERENCE HIGHLIGHT ADVANCEMENTS IN PROTEIN BIOTHERAPEUTIC CHARGE HETEROGENEITY CHARACTERIZATION USING THE MauriceFlex™ SYSTEM

January 23, 2024

Bio-Techne to host conference call on February 1, 2024, to announce second quarter fiscal 2024 financial results

January 15, 2024

Bio-Techne announces appointment of matthew f. McManus as President, Diagnostics and Genomics Segment

January 4, 2024

Bio-Techne to showcase cell and gene therapy manufacturing tools at phacilitate advanced therapies week 2024

January 3, 2024

Calls in 2024

Decks in 2024